Skip to main content
Log in

Effect of Shexiang Tongxin Dropping Pills (麝香通心滴丸) on the Immediate Blood Flow of Patients with Coronary Slow Flow

  • Clinical Experience
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To observe the immediate effect and safety of Shexiang Tongxin dropping pills (麝香通心滴丸, STDP) on patients with coronary slow flow (CSF), and furthermore, to explore new evidence for the use of Chinese medicine in treating ischemic chest pain.

Methods

Coronary angiography (CAG) with corrected thrombolysis in myocardial infarction (TIMI) frame count (CTFC) was applied (collected at 30 frames/s). The treatment group included 22 CSF patients, while the control group included 22 individuals with normal coronary flow. CSF patients were given 4 STDP through sublingual administration, and CAG was performed 5 min after the medication. The immediate blood flow frame count, blood pressure, and heart rate of patients before and after the use of STDP were compared. The liver and kidney functions of patients were examined before and after treatments.

Results

There was a significant difference in CTFC between groups (P<0.05). The average CTFC values of the vessels with slow blood flow in CSF patients were, respectively, 49.98 ± 10.01 and 40.42 ± 11.33 before and after the treatment with STDP, a 19.13% improvement. The CTFC values (frame/s) measured before and after treatment at the left anterior descending coronary artery, left circumflex artery, and right coronary artery were, respectively, 48.00 ± 13.32 and 41.80 ± 15.38, 59.00 ± 4.69 and 50.00 ± 9.04, and 51.90 ± 8.40 and 40.09 ± 10.46, giving 12.92%, 15.25%, and 22.76% improvements, respectively. The CTFC values of vessels with slow flow before treatment were significantly decreased after treatment (P<0.05). There were no apparent changes in the heart rate, blood pressure, or liver or kidney function of CSF patients after treatment with STDP (all P>0.05).

Conclusions

The immediate effect of STDP in treating CSF patients was apparent. This medication could significantly improve coronary flow without affecting blood pressure or heart rate. Our findings support the potential of Chinese medicine to treat ischemic chest pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries–a new angiographic finding. Am Heart J 1972;84:66–71.

    Article  CAS  PubMed  Google Scholar 

  2. Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow–prevalence and clinical correlations. Circ J 2012;76:936–942.

    Article  PubMed  Google Scholar 

  3. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001;87:777–779.

    Article  CAS  PubMed  Google Scholar 

  4. Wang SH, Zhu N, Zhou HL, Chen LB, Cui HB. Evaluation of myocardial perfusion in patients with coronary slow flow by myocardial contrast echocardiography. Chin J Cardiol (Chin) 2013;41:293–296.

    Google Scholar 

  5. Chu L, Wang SH, Zhou HL, Zhu N, Chen XM. Potential of Shexiang Tongxin Dropping Pills on the coronary slow flow phenomenon. Zhejiang J Integr Tradit Chin West Med (Chin) 2011;21:399–400.

    Google Scholar 

  6. Xu Z, Wang SH. Progress of drug treatment in the coronary slow flow phenomenon. Chin Circ J (Chin) 2015:81–83.

    Google Scholar 

  7. Zhu N, Wang SH, Liu YH, Zhou HL. Levels of nitric oxide and endothelin-1 in patients with coronary slow flow. Chin J Geriatric Heart Brain Vessel Dis (Chin) 2012;14:828–830.

    CAS  Google Scholar 

  8. Wang PL, Zhang L, Wang SL, Yang QN, Gao ZY, Du JP, et al. Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial. Chin J Integr Med 2017;23:740–746.

    Article  PubMed  Google Scholar 

  9. Shi HZ, Li YZ, Tang ZZ, Zhong CF, Fan QC, Gao JY, et al. Impact of 60 days of 6° head down bed rest on cardiopulmonary function, and the effects of Taikong Yangxin Prescription (麝香通心滴丸) as a countermeasure. Chin J Integr Med 2014;20:654–660.

    Article  PubMed  Google Scholar 

  10. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon–a new coronary microvascular disorder. Cardiology 2002;97:197–202.

    Article  PubMed  Google Scholar 

  11. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr., Alexander B Jr., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879–888.

    Article  CAS  PubMed  Google Scholar 

  12. Chan PS, Jones PG, Arnold SA, Spertus JA. Development and validation of a short version of the Seattle angina questionnaire. Circ Cardiovasc Qual Outcomes 2014;7:640–647.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Mangieri E, Macchiarelli G, Ciavolella M, Barilla F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996;37:375–381.

    Article  CAS  PubMed  Google Scholar 

  14. Fineschi M, Gori T. Coronary slow-flow phenomenon or syndrome Y: a microvascular angina awaiting recognition. J Am Coll Cardiol 2010;56:239–240.

    Article  PubMed  Google Scholar 

  15. Celebi H, Catakoglu AB, Kurtoglu H, Sener M, Hanavdelogullari R, Demiroglu C, et al. The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries. Cardiovasc Revasc Med 2008;9:144–148.

    Article  PubMed  Google Scholar 

  16. Yucel H, Ozaydin M, Dogan A, Erdogan D, Turker Y, Ceyhan BM. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow. Scand J Clin Lab Invest 2012;72:495–500.

    Article  CAS  PubMed  Google Scholar 

  17. Sadamatsu K, Tashiro H, Yoshida K, Shikada T, Iwamoto K, Morishige K, et al. Acute effects of isosorbide dinitrate and nicorandil on the coronary slow flow phenomenon. Am J Cardiovasc Drugs 2010;10:203–208.

    Article  CAS  PubMed  Google Scholar 

  18. Ozdogru I, Zencir C, Dogan A, Orscelik O, Inanc MT, Celik A, et al. Acute effects of intracoronary nitroglycerin and diltiazem in coronary slow flow phenomenon. J Investig Med 2013;61:45–49.

    Article  CAS  PubMed  Google Scholar 

  19. Chang SF, Ma JY, Qian JY, Shu XH, Ge JB. Effects of intracoronary administration of nitroglycerin and verapamil for treatment of coronary slow flow phenomenon. Chin J Cardiol (Chin) 2010;38:27–30.

    CAS  Google Scholar 

  20. Chen D, Lin S, Xu W, Huang M, Chu J, Xiao F, et al. Qualitative and quantitative analysis of the major constituents in Shexiang Tongxin Dropping Pill by HPLC-Q-TOF-MS/MS and UPLC-QqQ-MS/MS. Molecules 2015;20:18597–18619.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Xiong M, Jia C, Cui J, Wang P, Du X, Yang Q, et al. Shexiang Tongxin dropping pill attenuates at herosclerotic lesions in ApoE deficient mouse model. J Ethnopharmacol 2015;159:84–92.

    Article  PubMed  Google Scholar 

  22. Jin JG, Shen HJ, Shan YL, Chen L, Zhao XY, Wang LR. Effect of two administration routes of Shenmai Injection on pulmonary gas exchange function after tourniquet-induced ischemia-reperfusion. Chin J Integr Med 2017;23:18–24.

    Article  PubMed  Google Scholar 

  23. Wang LF, Xu ZY, Wang ZQ, Zhang M, Yan GY, Hou AJ, et al. Clinical observation of Shuanghuang Shengbai Granule on prevention and treatment of myelosuppression caused by chemotherapy in cancer patients. Chin J Integr Med 2017;23:105–109.

    Article  PubMed  Google Scholar 

  24. Liu XD, Wang YQ, Cai L, Ye LH, Wang F, Feng YY. Effect of Wenhua Juanbi Recipe (sic) on expression of receptor activator of nuclear factor kappa B ligand, osteoprotegerin, and tumor necrosis factor receptor superfamily member 14 in rats with collagen-induced arthritis. Chin J Integr Med 2017;23:208–214.

    Article  PubMed  Google Scholar 

  25. Wang Y, Niu ZC, He B, Xie XG, Liu J, Wang WM. Potential of Shexiang Tongxin Dropping Pills. Chin J Integr Med Cardio/Cerebrovas Dis (Chin) 2011;9:1083–1086.

    Article  Google Scholar 

  26. Zhang HQ, Xu DL, Yan L, Yuan LY, Jia JGo, Sun AJ, et al. The protective function of Shexiang on endothelial injury induced by angiotensin II osmotic pump in the rat. Chin J Clin Med (Chin) 2009;16:669–672.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sheng-huang Wang.

Additional information

Supported by the Zhejiang Institute of Integrative Medicine Clinical Special Fund for Pharmacy Research (No. 2014LYK009)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Sh., Chu, L., Xu, Z. et al. Effect of Shexiang Tongxin Dropping Pills (麝香通心滴丸) on the Immediate Blood Flow of Patients with Coronary Slow Flow. Chin. J. Integr. Med. 25, 360–365 (2019). https://doi.org/10.1007/s11655-018-2559-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-018-2559-4

Keywords

Navigation